Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
D000336:Aerosols; D001249:Asthma / Q000188:drug therapy; D001286:Atropine Derivatives; D001980:Bronchi; D001986:Bronchial Spasm / Q000517:prevention & control; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D009921:Metaproterenol / Q000627:therapeutic use*; D009129:Muscle Tonus; D010636:Phenols / Q000627:therapeutic use; D014326:Tropanes / Q000627:therapeutic use
D000336:Aerosols; D001286:Atropine Derivatives; D001993:Bronchodilator Agents; D004338:Drug Combinations; D010636:Phenols; D014326:Tropanes; D009921:Metaproterenol; D009241:Ipratropium